North Chicago Business
-
Research: Merck AIDS drug as effective as Abbott pillsJul 18, 2010 11:00 pm - Merck & Co.'s Isentress tablets suppressed HIV as successfully as older drugs by Abbott Laboratories and Gilead Sciences Inc., according to research that may spur sales....
-
Abbott Labs plans $3 billion debt offeringMay 23, 2010 11:00 pm - Abbott Laboratories, maker of the arthritis drug Humira, may issue $3 billion of notes in the biggest U.S. corporate bond sale in a month. The offering comprises $750 mi...
-
Abbott buys unit of Piramal Healthcare for $3.7 bilMay 20, 2010 11:00 pm - MUMBAI, India -- Abbott Laboratories has agreed to buy the domestic healthcare business of India's Piramal Healthcare Ltd., a leading branded generics company, for $3.72...
-
Abbott's Humira to be covered by U.K. national health plansMay 18, 2010 11:00 pm - Abbott Laboratories' Humira and Merck & Co.'s Remicade should be covered by the U.K.'s National Health Service for adults with severe Crohn's disease that doesn't respon...
-
Abbott Labs 1Q profit falls 30 percent, revenue climbsApr 20, 2010 11:00 pm - Abbott Laboratories' first-quarter profit met Wall Street expectations on better-than-expected sales of its drug Humira, though the company lowered its profit outlook du...
-
Abbott ordered to turn over e-mails for gov't probeApr 12, 2010 11:00 pm - WASHINGTON - A federal judge has ordered drugmaker Abbott Laboratories to hand over thousands of e-mails in connection with a government investigation into whether the c...
-
Abbott silent on possible Boston Scientific spinoffsApr 08, 2010 11:00 pm - Boston Scientific Corp., the world's second-largest maker of heart devices, is seeking buyers for its Target Therapeutics and neuromodulation units, said a person with k...
-
Abbott sues Lupin to block generic TriLipixMar 31, 2010 11:00 pm - Abbott Laboratories, the maker of the arthritis medicine Humira, sued Lupin Ltd. to prevent the generic-drug maker from selling a copy of the cholesterol drug TriLipix i...
-
Abbott: FDA wants more info on CertriadMar 29, 2010 11:00 pm - AstraZeneca Plc and Abbott Laboratories said U.S. regulators requested additional information on their Certriad heart treatment. The drugmakers, in a statement today, di...
-
Small businesses see pros, cons of new health care lawMar 24, 2010 11:00 pm - Small businesses will either thrive or struggle to survive under the nation's new health care law. Those two sides of the debate are offered by U.S. Rep. Melissa Bean, a...